Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

IEX Schedule One Update

6 Jun 2007 17:27

First Derivatives PLC06 June 2007 IEX SCHEDULE ONE-PRE-ADMISSION ANNOUNCEMENT COMPANY NAME: First Derivatives public limited companyCOUNTRY OF INCORPORATION: Northern IrelandCOMPANY ADDRESS: Registered Office: 40 Church Street, Belfast, Co Antrim, BT1 4FRCOMPANY BUSINESS OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGY TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE TWO, PARAGRAPH (J) OF THE IEX RULES: First Derivatives plc provides a range of services and software to the capital markets industry. Our customers includeinvestment banks, hedge funds, Specialised Investment Vehicles and Derivatives Product Companies as well as softwarecompanies selling to these organisations. Our range of services include project management and integration services,outsourced systems development and support, training and the provision of niche trading and risk managementapplications.DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares): 12,994,158 Ordinary shares of 0.5 pence eachCAPITAL TO BE RAISED ON ADMISSION: None FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS: Robert David Anderson - Non-executive chairman Brian Gerard Conlon - Managing director Michael George O'Neill - Operations Director Adrian John Toner - Non-executive DirectorPERSON(S) INTERESTED IN 5% OR MORE OF THE ISSUER CAPITAL, EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL BEFORE AND AFTER ADMISSION: Brian Gerard Conlon - 70.1% Michael George O'Neill 8.0%NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE TWO, PARAGRAPH (H) OF THE IEX RULES: NoneANTICIPATED ACCOUNTING REFERENCE DATE: 28 FebruaryEXPECTED ADMISSION DATE: 8 June 2007NAME AND ADDRESS OF IEX ADVISER: Goodbody Corporate Finance, Ballsbridge Park, Ballsbridge, Dublin 4NAME AND ADDRESS OF BROKER:Goodbody Stockbrokers, Ballsbridge Park, Ballsbridge, Dublin 4 DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIESN/ADATE OF NOTIFICATION: 10 May 2007QUOTED APPLICANTS MUST ALSO COMPLETE THE FOLLOWING: THE NAME OF THE IEX DESIGNATED MARKET UPON WHICH THE APPLICANT SECURITIES HAVE BEEN TRADED: AIM market of the London Stock Exchange THE DATE FROM WHICH THE APPLICANT SECURITIES HAVE BEEN SO TRADED: 28 March 2002CONFIRMATION THAT, FOLLOWING DUE AND CAREFUL ENQUIRY, THE APPLICANT HAS ADHERED TO ANY LEGAL AND REGULATORYREQUIREMENTS INVOLVED IN HAVING ITS SECURITIES TRADED UPON SUCH A MARKET: First Derivatives confirms, having made due and careful enquiry, that as at the date of this announcement the Companyhas adhered to the legal and regulatory requirements involved in having its securities traded on the AIM market of theLondon Stock Exchange. AN ADDRESS OR WEB-SITE ADDRESS WHERE ANY DOCUMENTS OR ANNOUNCEMENTS WHICH THE APPLICANT HAS MADE PUBLIC OVER THE LAST TWO YEARS (IN CONSEQUENCE OF HAVING ITS SECURITIES SO TRADED) ARE AVAILABLE: www.firstderivatives.comDETAILS OF THE APPLICANT STRATEGY FOLLOWING ADMISSION INCLUDING, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGYFirst Derivatives plc will continue to pursue its current strategy of maximising shareholder value by growing itsbusiness within each of its 3 main profit centres. Personnel can transfer seamlessly between these centres andopportunities exist for cross-selling services and software. Capital Markets First Derivatives will continue to expand relationships with existing customers and to seek new customers for itsgeneral consulting services. The company has a strong brand and a critical mass of consultants which will allow it tofocus on providing teams of highly skilled consultants on long-term projects or projects with a significant potentialfor recurring revenue. Sales Partnerships First Derivatives operates partnerships with a number of non-competing software vendors, including one with KX Systems(www.kx.com). New opportunities will be sought to expand the portfolio of partners and to increase revenue fromexisting partnerships. These partnerships allow more points of entry for establishing direct relationships withinvestment banking customers. Product Development A number of R&D initiatives are on the verge of commercial exploitation. These are in areas such as algorithmic programtrading, compliance and market data management. A DESCRIPTION OF ANY SIGNIFICANT CHANGE IN FINANCIAL OR TRADING POSITION OF THE APPLICANT, WHICH HAS OCCURRED SINCE THE END OF THE LAST FINANCIAL PERIOD FOR WHICH AUDITED STATEMENTS HAVE BEEN PUBLISHED: Otherwise than disclosed in the Company public records, there has been no significant change in the financial ortrading position of the Company since 28 February 2007, the end of the last financial year for which audited financialstatements have been published. A STATEMENT THAT THE DIRECTORS OF THE APPLICANT HAVE NO REASON TO BELIEVE THAT THE WORKING CAPITAL AVAILABLE TO IT OR ITS GROUP WILL BE INSUFFICIENT FOR AT LEAST TWELVE MONTHS FROM THE DATE OF ITS ADMISSION: The directors of the Company have no reason to believe that the working capital available to it or its group will be insufficient for at least twelve months from the date of its admission. DETAILS OF ANY LOCK-IN ARRANGEMENTS PURSUANT TO RULE 7 OF THE IEX RULES: NoneA BRIEF DESCRIPTION OF THE ARRANGEMENTS FOR SETTLING THE APPLICANT SECURITIES: Following Admission settlement of transactions in the Ordinary Shares may take place within the CREST system ifShareholders so wish. CREST is a voluntary system and holders of Ordinary Shares who wish to receive and retain sharecertificates will be able to do. A WEBSITE ADDRESS DETAILING THE RIGHTS ATTACHING TO THE APPLICANT SECURITIES: Details are contained in the Admission Document available at www.firstderivatives.com INFORMATION EQUIVALENT TO THAT REQUIRED FOR AN ADMISSION DOCUMENT WHICH IS NOT CURRENTLY PUBLIC: Not applicable A WEBSITE ADDRESS OF A PAGE CONTAINING THE APPLICANT LATEST ANNUAL REPORT AND ACCOUNTS WHICH MUST HAVE A FINANCIAL YEAR END NOT MORE THAN NINE MONTHS PRIOR TO ADMISSION AND FULLY AUDITED INTERIM RESULTS WHERE APPLICABLE. THE ACCOUNTS MUST BE PREPARED ACCORDING TO IRISH, UK OR US GAAP OR INTERNATIONAL ACCOUNTING STANDARDS. www.firstderivatives.comTHE NUMBER OF EACH CLASS OF SECURITIES HELD IN TREASURY. None This announcement has been issued through the Companies Announcement Service of The Irish Stock Exchange. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Oct 20237:00 amRNSNotice of Results
31st Aug 20239:18 amRNSTotal Voting Rights
15th Aug 20237:00 amRNSIssue of Equity
31st Jul 20231:59 pmRNSTotal Voting Rights
20th Jul 20233:30 pmRNSResult of AGM
28th Jun 20234:17 pmRNSPDMR Notice and Issue of Equity
27th Jun 20234:30 pmRNSNotice of AGM
5th Jun 202312:43 pmRNSHolding(s) in Company
30th May 20231:01 pmRNSHolding(s) in Company
23rd May 20237:00 amRNSResults for the year ended 28 February 2023
18th May 20237:00 amRNSKX partnering with Amazon Web Services
5th Apr 20237:00 amRNSLTIP Award
4th Apr 20231:51 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSFY23 trading update
20th Mar 20237:00 amRNSGeneral availability of kdb Insights Enterprise
28th Feb 20238:39 amRNSTotal Voting Rights
13th Feb 20234:43 pmRNSIssue of Equity
30th Dec 202210:06 amRNSTotal Voting Rights
22nd Dec 20224:15 pmRNSHolding(s) in Company
20th Dec 20224:02 pmRNSIssue of Equity
14th Dec 20222:01 pmRNSHolding(s) in Company
30th Nov 20228:47 amRNSTotal Voting Rights
15th Nov 20227:00 amRNSIssue of Equity
31st Oct 20227:00 amRNSDirector/PDMR Shareholding
21st Oct 202211:38 amRNSDirector/PDMR Shareholding
18th Oct 20227:00 amRNSResults for the six months ended 31 August 2022
6th Oct 20222:02 pmRNSHolding(s) in Company
22nd Sep 20228:06 amRNSHolding(s) in Company
7th Sep 20227:00 amRNSNotice of Results
31st Aug 202210:09 amRNSTotal Voting Rights
16th Aug 20225:50 pmRNSIssue of Equity
5th Aug 20227:00 amRNSAppointment of Ashok Reddy as CEO of KX
2nd Aug 20229:49 amRNSHolding(s) in Company
29th Jul 202210:43 amRNSTotal Voting Rights
19th Jul 20227:00 amRNSIssue of Equity
7th Jul 20223:24 pmRNSResult of AGM
30th Jun 202212:30 pmRNSTotal Voting Rights
23rd Jun 20226:01 pmRNSIssue of Equity
8th Jun 20223:43 pmRNSNotice of AGM
31st May 202210:18 amRNSTotal Voting Rights
23rd May 20226:31 pmRNSRNS PDMR notice Issue of Equity
10th May 20227:00 amRNSResults for the year ended 28 February 2022
3rd May 20223:00 pmRNSHolding(s) in Company
26th Apr 20226:17 pmRNSHolding(s) in Company
11th Apr 20226:28 pmRNSTR1 - Notification of Major Holdings
6th Apr 20227:00 amRNSTrading update
5th Apr 20227:00 amRNSHolding(s) in Company
1st Mar 20227:00 amRNSKX Strategic Partnership Agreement with Microsoft
28th Feb 20225:52 pmRNSIssue of Equity
3rd Feb 20221:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.